Britain backs GSK gene therapy for BUBBLE BOY syndrome Ruby Khatun Khatun23 Oct 2017 9:32 AM ISTGlaxoSmithKline's (GSK) gene therapy for the so-called "bubble boy" disease was approved by Britain's healthcare cost watchdog NICE, despite a price...
DBV Technologies peanut allergy drug fails key study Ruby Khatun Khatun23 Oct 2017 9:15 AM ISTDBV Technologies SA said on Friday its peanut allergy treatment did not meet the main goal in a highly anticipated late-stage study, sending its...
Exelixis drug improves overall survival in liver cancer patients Ruby Khatun Khatun21 Oct 2017 9:12 AM ISTExelixis Inc's drug to treat a type of liver cancer improved overall survival in patients in a late-stage study that prompted an independent expert...
Johnson and Johnson psoriasis drug gets expanded US approval for teens Ruby Khatun Khatun15 Oct 2017 9:47 AM ISTJohnson and Johnson said on Friday it has received an expanded U.S. approval for its blockbuster psoriasis drug Stelara to treat adolescent patients...
To market new drugs in India, global trials must include Indians Ruby Khatun Khatun12 Oct 2017 3:21 PM ISTNew Delhi: The drug regulator in a recent technical committee meeting, headed by Jagdish Prasad, Director General of Health Services, has made it...
Intas Pharma cuts down price of cancer drug Bevacizumab by 60 percent Ruby Khatun Khatun6 Oct 2017 11:12 AM ISTAHMEDABAD: Intas Pharmaceuticals Limited, announced that the company is cutting down the cost of the cancer drug Bevacizumab by 60 percent in order to...
Zydus gets USFDA nod for overactive bladder drug Ruby Khatun Khatun6 Oct 2017 9:49 AM ISTNew Delhi: Drug firm Zydus Cadila said it has received final approval from the US health regulator to market capsules used in treating overactive...
Cigna to end OxyContin painkiller coverage, signs contract for alternative Ruby Khatun Khatun6 Oct 2017 9:30 AM ISTAmid a growing U.S. opioid addiction, health insurer Cigna Corp will stop covering OxyContin, the opioid painkiller sold by Purdue Pharma LP, as of...
Integra LifeScience acquires codman neurosurgery business from Johnson and Johnson Ruby Khatun Khatun6 Oct 2017 9:15 AM ISTPLAINSBORO, N.J.: Integra LifeSciences Holdings Corporation, a global leader in medical technology, announced that it has completed the previously...
US House committee launches probe of Allergan patent deal Ruby Khatun Khatun6 Oct 2017 9:00 AM ISTNEW YORK: A U.S. House of Representatives committee launched a probe into drugmaker Allergan Plc's deal to transfer some of its patents to a Native...
Fosun Pharma acquires 74 percent stake in Gland Pharma for 1.09 billion dollar Ruby Khatun Khatun5 Oct 2017 10:53 AM ISTNew Delhi: Chinese drug firm Fosun Pharma has acquired approximately 74 percent in Hyderabad-based Gland Pharma at a valuation of not more than USD...
Zydus gets USFDA nod to market anti-diuretic nasal spray Ruby Khatun Khatun5 Oct 2017 10:17 AM ISTNew Delhi: Drug firm Zydus Cadila said it has received final approval from the US health regulator to market anti-diuretic Desmopressin nasal spray...
